MAR vs REGN · P/E 32, rev $26.19B vs P/E 14, rev $14.34B
Marriott International Inc (MAR) versus Regeneron Pharmaceuticals Inc (REGN) — a side-by-side from cached financials, not a winner call.
Marriott International Inc (MAR) is a lodging company listed on US.
Regeneron Pharmaceuticals Inc (REGN) is a biotechnology company listed on US.
Latest reported MAR revenue for 2025-12-31 was $26.19B. Net income was $2.60B. Revenue was up 4.3% from 2024-12-31 to 2025-12-31. MAR currently screens at market cap $76.70B and trailing P/E 31.9.
Latest reported REGN revenue for 2025-12-31 was $14.34B. Net income was $4.50B. Revenue was up 1.0% from 2024-12-31 to 2025-12-31. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
MAR currently screens at market cap $76.70B and trailing P/E 31.9. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
Not investment advice. Open the MAR and REGN stock pages for the full models.
Not investment advice.